共 50 条
- [31] Pharmacoeconomic evaluation of using enzalutamide for treatment of patients with metastatic hormone-sensitive prostate cancer ONKOUROLOGIYA, 2022, 18 (01): : 90 - 105
- [32] The Treatment of Metastatic , Hormone-Sensitive Prostatic Carcinoma DEUTSCHES ARZTEBLATT INTERNATIONAL, 2022, 119 (37): : 622 - +
- [35] Rezvilutamide for metastatic hormone-sensitive prostate cancer LANCET ONCOLOGY, 2022, 23 (11): : E490 - E490
- [37] Docetaxel for hormone-sensitive metastatic prostate cancer LANCET ONCOLOGY, 2015, 16 (09): : E432 - E432